It was recently reported that gain-of-function mutations in STING results in STING-associated vasculopathy with onset in infancy (SAVI), a syndrome characterized by a severe cutaneous vasculopathy leading to extensive tissue loss and structural damage, with neonatal-onset systemic inflammation [18–20]. The gene discussed is STING1; the disease is vascular disorder.